Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paris Margaritis

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Plos One|June 30, 2018
Development and testing of AAV-delivered single-chain variable fragments for the treatment of methamphetamine abuseCharles E Hay, Guillermo A Gonzalez, Laura E Ewing, et al.
Nature Biotechnology|October 25, 2011
A zymogen-like factor Xa variant corrects the coagulation defect in hemophiliaLacramioara Ivanciu, Raffaella Toso, Paris Margaritis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 2, 2025
Recovery of cone-mediated vision in Lebercilin associated retinal ciliopathy after gene therapy: One-year results of a phase I/II trialTomas S Aleman, Katherine E Uyhazi, Alejandro J Roman, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Plos One|June 30, 2018
Development and testing of AAV-delivered single-chain variable fragments for the treatment of methamphetamine abuseCharles E Hay, Guillermo A Gonzalez, Laura E Ewing, et al.
Nature Biotechnology|October 25, 2011
A zymogen-like factor Xa variant corrects the coagulation defect in hemophiliaLacramioara Ivanciu, Raffaella Toso, Paris Margaritis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 2, 2025
Recovery of cone-mediated vision in Lebercilin associated retinal ciliopathy after gene therapy: One-year results of a phase I/II trialTomas S Aleman, Katherine E Uyhazi, Alejandro J Roman, et al.
Pageof 3